Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for TLCC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
December 31, 2024 35.17%
September 30, 2024 27.65%
June 30, 2024 39.32%
March 31, 2024 30.37%
December 31, 2023 32.25%
September 30, 2023 36.21%
June 30, 2023 38.88%
March 31, 2023 39.56%
December 31, 2022 60.64%
September 30, 2022 41.03%
June 30, 2022 25.99%
March 31, 2022 33.42%
December 31, 2021 -8.73%
September 30, 2021 33.07%
June 30, 2021 26.70%
March 31, 2021 36.58%
December 31, 2020 -4.19%
September 30, 2020 20.15%
June 30, 2020 23.12%
March 31, 2020 31.43%
December 31, 2019 11.66%
Date Value
September 30, 2019 8.38%
June 30, 2019 30.51%
March 31, 2019 11.30%
December 31, 2018 17.16%
September 30, 2018 8.08%
June 30, 2018 22.54%
March 31, 2018 20.72%
December 31, 2017 16.78%
September 30, 2017 17.02%
June 30, 2017 26.39%
March 31, 2017 27.39%
December 31, 2016 22.57%
September 30, 2016 30.73%
June 30, 2016 26.89%
March 31, 2016 16.60%
December 31, 2015 10.21%
September 30, 2015 14.72%
June 30, 2015 15.51%
March 31, 2015 16.36%
December 31, 2014 18.59%
September 30, 2014 21.67%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Reliv' International, Inc. 46.68%
Natural Health Trends Corp. 74.94%
Stemsation International, Inc. --
Stephan Co. 29.62%
Upexi, Inc. 93.11%